Retifanlimab with Bevacizumab and Hypofractionated Radiotherapy for the Treatment of Recurrent Glioblastoma
Clinical trial NCT06160206 · RECRUITING
Trial details
- NCT number
- NCT06160206
- Sponsor
- Academic and Community Cancer Research United
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-02
- Primary completion
- 2026-11-30
- Enrollment
- 134
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.